A carregar...
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
Tivozanib is a novel vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGF TKI). Among other VEGF TKIs, tivozanib stands apart due to its selective kinase inhibitory properties as well as its high potency for inhibiting VEGF receptors 1 and 2. Tivozanib has been evaluated in se...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3693745/ https://ncbi.nlm.nih.gov/pubmed/23818763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S31442 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|